$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells 원문보기

International journal of molecular sciences, v.21 no.8, 2020년, pp.2871 -   

Kim, Hyungkeun (Department of Applied Life Science, The Graduate School, Yonsei University, Seoul 03722, Korea) ,  Lee, Joo-Hee (khg165@gmail.com (H.K.)) ,  Lee, Sun Kyoung (lpluto@yuhs.ac (S.K.L.)) ,  Song, Na-Young (nysong608@yuhs.ac (N.-Y.S.)) ,  Son, Seung Hwa (Department of Oral Biology and BK21 PLUS Project, Yonsei University College of Dentistry, Seoul 03722, Korea) ,  Kim, Ki Rim (jhlee1201@yuhs.ac (J.-H.L.)) ,  Chung, Won-Yoon (shson0729@yuhs.ac (S.H.S.))

Abstract AI-Helper 아이콘AI-Helper

Chemerin is secreted as prochemerin from various cell types and then cleaved into the bioactive isoform by specific proteases. In various cancer types, chemerin exhibits pro- or antitumor effects. In the present study, chemerin treatment significantly inhibited the viability and invasion of breast c...

주제어

참고문헌 (41)

  1. 1. Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Specific recruitment of antigen-presenting cells by chemerin, novel processed ligand from human inflammatory fluids J. Exp. Med. 2003 198 977 985 10.1084/jem.20030382 14530373 

  2. 2. Zabel B.A. Allen S.J. Kulig P. Allen J.A. Cichy J. Handel T.M. Butcher E.C. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades J. Biol. Chem. 2005 280 34661 34666 10.1074/jbc.M504868200 16096270 

  3. 3. Goralski K.B. McCarthy T.C. Hanniman E.A. Zabel B.A. Butcher E.C. Parlee S.D. Muruganandan S. Sinal C.J. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism J. Biol. Chem. 2007 282 28175 28188 10.1074/jbc.M700793200 17635925 

  4. 4. Banas M. Zabieglo K. Kasetty G. Kapinska-Mrowiecka M. Borowczyk J. Drukala J. Murzyn K. Zabel B.A. Butcher E.C. Schroeder J.M. Chemerin is an antimicrobial agent in human epidermis PLoS ONE 2013 8 e58709 10.1371/annotation/4dfd522c-f0fd-40db-aadc-44cbef367a40 23527010 

  5. 5. Shen W. Tian C. Chen H. Yang Y. Zhu D. Gao P. Liu J. Oxidative stress mediates chemerin-induced autophagy in endothelial cells Free Radic. Biol. Med. 2013 55 73 82 10.1016/j.freeradbiomed.2012.11.011 23195684 

  6. 6. Zhang J. Jin H.C. Zhu A.K. Ying R.C. Wei W. Zhang F.J. Prognostic significance of plasma chemerin levels in patients with gastric cancer Peptides 2014 61 7 11 10.1016/j.peptides.2014.08.007 25152503 

  7. 7. Liu-Chittenden Y. Patel D. Gaskins K. Giordano T.J. Assie G. Bertherat J. Kebebew E. Serum RARRES2 is a prognostic marker in patients with adrenocortical carcinoma J. Clin. Endocrinol. Metab. 2016 101 3345 3352 10.1210/jc.2016-1781 27336360 

  8. 8. Ghallab N.A. Shaker O.G. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions Clin. Oral Investig. 2017 21 937 947 10.1007/s00784-016-1846-8 

  9. 9. Xu C.H. Yang Y. Wang Y.C. Yan J. Qian L.H. Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer Oncotarget 2017 8 22483 22489 10.18632/oncotarget.14956 28160556 

  10. 10. Sotiropoulos G.P. Dalamaga M. Antonakos G. Marinou I. Vogiatzakis E. Kotopouli M. Karampela I. Christodoulatos G.S. Lekka A. Papavassiliou A.G. Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer Lung Cancer 2018 125 291 299 10.1016/j.lungcan.2018.10.010 30429035 

  11. 11. Alkady M.M. Abdel-Messeih P.L. Nosseir N.M. Assessment of Serum Levels of the Adipocytokine Chemerin in Colorectal Cancer Patients J. Med. Biochem. 2018 37 313 319 10.1515/jomb-2017-0062 30598628 

  12. 12. Kiczmer P. Szydło B. Sekowska A.P. Jopek J. Wiewiora M. Piecuch J. Ostrowska Z. witochowska E. Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis Folia Med. Cracov. 2018 58 77 87 30467436 

  13. 13. Lin W. Chen Y.L. Jiang L. Chen J.K. Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma Clin. Lab. 2011 57 879 885 22239017 

  14. 14. Liu-Chittenden Y. Jain M. Gaskins K. Wang S. Merino M.J. Kotian S. Kumar Gara S. Davis S. Zhang L. Kebebew E. RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma Oncogene 2017 36 3541 3552 10.1038/onc.2016.497 28114280 

  15. 15. Pachynski R.K. Zabel B.A. Kohrt H.E. Tejeda N.M. Monnier J. Swanson C.D. Holzer A.K. Gentles A.J. Sperinde G.V. Edalati A. The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses J. Exp. Med. 2012 209 1427 1435 10.1084/jem.20112124 22753924 

  16. 16. Wang C. Wu W.K. Liu X. To K.F. Chen G.G. Yu J. Ng E.K. Increased serum chemerin level promotes cellular invasiveness in gastric cancer: A clinical and experimental study Peptides 2014 51 131 138 10.1016/j.peptides.2013.10.009 24274970 

  17. 17. Kumar J.D. Aolymat I. Tiszlavicz L. Reisz Z. Garalla H.M. Beynon R. Simpson D. Dockray G.J. Varro A. Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: Putative role of decreased TIMP-1 and TIMP-2 Oncotarget 2019 10 98 112 10.18632/oncotarget.26414 30719206 

  18. 18. Kumar J.D. Kandola S. Tiszlavicz L. Reisz Z. Dockray G.J. Varro A. The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancercells Br. J. Cancer 2016 114 1152 1159 10.1038/bjc.2016.93 27092781 

  19. 19. Pachynski R.K. Wang P. Salazar N. Zheng Y. Nease L. Rosalez J. Leong W.I. Virdi G. Rennier K. Shin W.J. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment Front. Immunol. 2019 10 983 10.3389/fimmu.2019.00983 31139180 

  20. 20. Lin Y. Yang X. Liu W. Li B. Yin W. Shi Y. He R. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation Oncogene 2017 36 3599 3608 10.1038/onc.2016.516 28166197 

  21. 21. Li J.J. Yin H.K. Guan D.X. Zhao J.S. Feng Y.X. Deng Y.Z. Wang X. Li N. Wang X.F. Cheng S.Q. Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis Br. J. Cancer 2018 118 1337 1348 10.1038/s41416-018-0077-y 29717200 

  22. 22. El-Sagheer G. Gayyed M. Ahmad A. Abd El-Fattah A. Mohamed M. Expression of chemerin correlates with a poor prognosis in female breast cancer patients Breast Cancer 2018 10 169 176 10.2147/BCTT.S178181 30498371 

  23. 23. Scher C. Haudenschild C. Klagsbrun M. The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells Cell 1976 8 373 382 10.1016/0092-8674(76)90149-5 182381 

  24. 24. Tania M. Khan M.A. Fu J. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer Tumour Biol. 2014 35 7335 7342 10.1007/s13277-014-2163-y 24880591 

  25. 25. Radisky E.S. Radisky D.C. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer J. Mammary Gland. Biol. Neoplasia 2010 15 201 212 10.1007/s10911-010-9177-x 20440544 

  26. 26. Demirkan B. The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment J. Clin. Med. 2013 2 264 282 10.3390/jcm2040264 26237148 

  27. 27. Zhang Y. Ma B. Fan Q. Mechanisms of breast cancer bone metastasis Cancer Lett. 2010 292 1 7 10.1016/j.canlet.2009.11.003 20006425 

  28. 28. Suva L.J. Washam C. Nicholas R.W. Griffin R.J. Bone metastasis: Mechanisms and therapeutic opportunities Nat. Rev. Endocrinol. 2011 7 208 218 10.1038/nrendo.2010.227 21200394 

  29. 29. Ohshiba T. Miyaura C. Inada M. Ito A. Role of RANKL-induced osteoclast formationand MMP-dependent matrix degradation in bonedestruction by breast cancer metastasis Br. J. Cancer 2003 88 1318 1326 10.1038/sj.bjc.6600858 12698202 

  30. 30. Rodriguez C. Freedland S.J. Deka A. Jacobs E.J. McCullough M.L. Patel A.V. Thun M.J. Calle E.E. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev. 2007 16 63 69 10.1158/1055-9965.EPI-06-0754 17179486 

  31. 31. Murphy T.K. Calle E.E. Rodriguez C. Kahn H.S. Thun M.J. Body mass index and colon ancer mortality in a large prospective study Am. J. Epidemiol. 2000 152 847 854 10.1093/aje/152.9.847 11085396 

  32. 32. Petrelli J.M. Calle E.E. Rodriguez C. Thun M.J. Body mass index, height, and ostmenopausal breast cancer mortality in a prospective cohort of US women Cancer Causes Control 2002 13 325 332 10.1023/A:1015288615472 12074502 

  33. 33. Booth A. Magnuson A. Fouts J. Foster M. Adipose tissue, obesity and adipokines: Role in cancer promotion Horm. Mol. Biol. Clin. Investig. 2015 21 57 74 10.1515/hmbci-2014-0037 25781552 

  34. 34. Christodoulatos G.S. Spyrou N. Kadillari J. Psallida S. Dalamaga M. The role of adipokines in breast cancer: Current evidence and perspectives Curr. Obes. Rep. 2019 8 413 433 10.1007/s13679-019-00364-y 31637624 

  35. 35. Mattern A. Zellmann T. Beck-Sickinger A.G. Processing, signaling, and physiological function of chemerin IUBMB Life 2014 66 19 26 10.1002/iub.1242 24446308 

  36. 36. Scanlon C.S. Van Tubergen E.A. Inglehart R.C. D’Silva N.J. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma J. Dent. Res. 2013 92 114 121 10.1177/0022034512467352 23128109 

  37. 37. Min C. Eddy S.F. Sherr D.H. Sonenshein G.E. NF-kappaB and epithelial to mesenchymal transition of cancer J. Cell. Biochem. 2008 104 733 744 10.1002/jcb.21695 18253935 

  38. 38. Shin E.M. Hay H.S. Lee M.H. Goh J.N. Tan T.Z. Sen Y.P. Lim S.W. Yousef E.M. Ong H.T. Thike A.A. DEAD-box helicase DP103 defines metastatic potential of human breast cancers J. Clin. Investig. 2014 124 3807 3824 10.1172/JCI73451 25083991 

  39. 39. Le Pape F. Vargas G. Clezardin P. The role of osteoclasts in breast cancer bone metastasis J. Bone Oncol. 2016 5 93 95 10.1016/j.jbo.2016.02.008 27761364 

  40. 40. Morris E.V. Edwards C.M. The role of bone marrow adipocytes in bone metastasis J. Bone Oncol. 2016 5 121 123 10.1016/j.jbo.2016.03.006 27761371 

  41. 41. Ma G.T. Lee S.K. Park K.K. Park J. Son S.H. Jung M. Chung W.Y. Artemisinin-Daumone Hybrid Inhibits Cancer Cell-Mediated Osteolysis by Targeting Cancer Cells and Osteoclasts Cell. Physiol. Biochem. 2018 49 1460 1475 10.1159/000493449 30205376 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로